It is essential to consult an eye care professional if you experience any changes in your vision or comfort. Early detection of potential issues can significantly improve treatment outcomes. You should schedule an appointment if you notice any of the following symptoms:

Sudden changes in vision: This includes sudden blurriness, double vision, or a complete loss of vision in one or both eyes.

Persistent eye discomfort: Symptoms such as ongoing eye pain, persistent itching, burning sensations, or a feeling of grittiness.

Visual disturbances: Frequent occurrences of flashes of light, a sudden increase in the number of "floaters" (small spots or cobwebs in your field of vision), or dark shadows/curtains obscuring part of your vision.

Light sensitivity: New or increased sensitivity to light (photophobia).

Difficulty with daily tasks: Noticeable strain while reading, driving at night, or inability to focus on objects at close or far distances.

Physical changes to the eye: Redness, swelling, discharge, or any visible changes to the appearance of the eyelid or eye structure.

If you experience sudden vision loss, severe eye pain, or severe injury to the eye, please seek immediate medical attention.

At our clinic, we pride ourselves on utilizing state-of-the-art diagnostic and surgical equipment. We are proud to be the exclusive provider of advanced Japanese ophthalmological technology in Georgia. This partnership allows us to offer our patients unmatched precision, reliability, and the highest standards of diagnostic accuracy, ensuring optimal treatment outcomes and patient safety.

Retinal photocoagulation is a laser treatment used to manage various retinal disorders by sealing leaking blood vessels, destroying abnormal tissue, or creating adhesions to prevent retinal detachment. The primary indications include:

Diabetic Retinopathy: Specifically, Proliferative Diabetic Retinopathy (PDR), where pan-retinal photocoagulation (PRP) is used to destroy ischemic retinal areas and stop the growth of abnormal new blood vessels (neovascularization) that can cause hemorrhage or blindness.

Retinal Tears and Breaks: Laser treatment is used to create a "weld" around the tear, effectively sealing the edges to the underlying tissue to prevent Retinal Detachment.

Retinal Vein Occlusion (RVO): Used to treat macular edema or secondary neovascularization resulting from the blockage of retinal veins.

Central Serous Chorioretinopathy (CSCR): In specific cases, to seal the point of leakage under the retina.

Intravitreal injections are a cornerstone of modern retinal therapy, allowing for the direct delivery of therapeutic agents—primarily anti-VEGF (Vascular Endothelial Growth Factor) medications or corticosteroids—into the vitreous cavity. This precise administration bypasses the blood-retinal barrier, ensuring maximal efficacy for several sight-threatening conditions:

Neovascular (Wet) Age-Related Macular Degeneration (nAMD): Intravitreal anti-VEGF therapy is the gold standard for inhibiting the growth of choroidal neovascular membranes, thereby preventing further central vision loss.

Diabetic Macular Edema (DME): Injections are indicated to reduce retinal vascular permeability and edema, which are primary drivers of vision impairment in diabetic patients.

Retinal Vein Occlusion (RVO): Intravitreal treatment is indicated to manage macular edema secondary to Central Retinal Vein Occlusion (CRVO) or Branch Retinal Vein Occlusion (BRVO).

Myopic Choroidal Neovascularization (mCNV): Patients with high myopia may develop abnormal vessel growth; intravitreal pharmacotherapy is highly effective in stabilizing these lesions.

Intraocular Inflammation (Uveitis): In selected cases, intravitreal corticosteroids are utilized to control severe inflammation when systemic therapy is insufficient or contraindicated.